http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090023434-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6171684de68ce62ef3fbf1655618249
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-6486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-534
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2009-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30df4af05acb075ba54fa31bb34a8fd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8534c5468d44687d850eaa8f8d3ab84d
publicationDate 2009-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20090023434-A
titleOfInvention Screening method of anticancer substance or anticancer treatment method using calcein-AM in multilayer cancer cell culture system
abstract The present invention relates to a method for screening an anticancer substance or anticancer treatment method using calcein-AM in a multicellular cancer cell (multicellular layer, MCL), specifically, one of the screening systems for the discovery of anticancer candidates effective for solid cancer The anticancer agent was treated by the anticancer candidate substance or candidate anticancer treatment method in the MCL model, followed by successive treatments with calcein-AM (calcein-acetoxymethyl ester), and by measuring the fluorescence intensity distribution of calcein-AM that has passed through the MCL. A method of screening a substance or anticancer treatment method. Using the method of the present invention can know the tissue permeability and anticancer effect of the anticancer candidate, it can be usefully used to search for or evaluate the efficacy of a new anticancer or anticancer therapy for solid cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107367456-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107367456-B
priorityDate 2009-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID390986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450455866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415956444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86598188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450235101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426017152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4126474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445025
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945

Total number of triples: 35.